CTTH.US CTT Pharmaceutical Holdings Inc

Healthcare Pharmaceuticals USA Stocks
0.0559 USD
Close of Nov 11, 2026
0.0350 0.1000
Market cap
USD 3.28M
P/E
-
P/B
125.92x
ROE
-767.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is CTTH.US undervalued?

Graham number

The Graham number of CTT Pharmaceutical Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CTT Pharmaceutical Holdings Inc fundamental analysis

No fundamental analysis for CTT Pharmaceutical Holdings Inc yet.

CTT Pharmaceutical Holdings Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CTT Pharmaceutical Holdings Inc

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The co…

Full company profile